Member Info for Timster

Daft to close though when avacta are in a death spiral

Hence the price being kept down so they could escape.

Mr R spot on

NY time 8.30, bagels and cwafee free flowing

It's all irrelevant anyway, these 1000 word essays can't save us from the death spiral.

Where's that truant twat:)

Simple fact is wynbore is you are extremely boring and talk down to people as you think you are better than them.

Oh look the market is pricing avacta at 99p now and not 95p as you stated.

Mates rates, load up

With the placing shares and convertible bonds settling tomorrow I'd imagine the SP won't do much until then.

Not read the RNS robin?
This financing allows us to progress our M&A-led growth strategy for Avacta's diagnostics division and progress a pipeline of potential acquisitions in the European diagnostics sector to build a fully integrated and differentiated diagnostics business with global reach alongside the continued funding of Avacta's Therapeutics division to progress AVA6000 through the clinic and further develop the broader oncology pipeline."

Someone knows something

I generally ignore Hurstbot when he posts M&A info but who'd have thought it would be Avacta doing the M&Aing

Sounds like a dictionary definition of a death spiral...

Will they close out?

It's a fake drug though that they'll quietly drop!

You are talking about ACA6k, right?

What did you do exactly? Did you set up the deal?

I don't get the title of the thread??

It's not the reaction the TWat crew were hoping for.....

I agree okehurst but maybe ava6k is already well over the line

It's not just a covid test, so many opportunities in diagnostic and replacing antibodies with affimers, that's what this is about.

But **** if they did.

But this isn't a raise from a distressed company.

I know it's all made up, but AVA6k, the drug that received orphan drug designation from the FDA enters is seventh week dosing patients at 200mg (equivalent of 135mg of dox, which would do serious harm if freely circulating in the body).

Probably a few more weeks to run, this positive progress reflects the safety profile and tolerability in patients (of this made up drug).